🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Émilie Mamessier

Centre National de la Recherche Scientifique

ORCID: 0000-0002-3516-0093

Also affiliated with Inserm, Centre de Recherche en Cancérologie de Marseille

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma”.

Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001435
N/A
0DataRank · unranked
151 citations

Aya Matsui, Hiroto Kikuchi, Sebastian Klein, Émilie Mamessier, Ivy X. Chen +21 more

Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma

Gut(2021)10.1136/gutjnl-2020-322493
N/A
0DataRank · unranked
81 citations

Koetsu Inoue, Sebastian Klein, Stefan Halvorsen, Jiang Chen, Aya Matsui +28 more

The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110091
N/A
0DataRank · unranked
9 citations

Sergey V. Kozin, Aya Matsui, Saveli Goldberg, Shuichi Aoki, Kohei Shigeta +6 more